Will Zoom report combined Net Dollar Expansion at or above 100% in any FY27 quarter (Q1-Q4)?

NDE has been flat at 98% for 4+ consecutive quarters with no recovery curve visible — Black Swan Beacon's parsimonious read explicitly weights this 40/60 leaning bear on the new-logo dilution mechanism. Compounding the bear case: a disclosed 40bps FY27 white-label customer churn headwind acts directly against NDE early in FY27, the Online tier (39% of revenue) shows accelerating churn (2.7%→2.9% Q3→Q4) with volume erosion implied by +1-2% growth on a 6% price hike, and zero insider open-market buys signals no NEO confidence in NDE recovery. The bull path (Workvivo/ZCC cohorts maturing into the trailing-12mo denominator over 4 quarterly shots) is real but unverified at E2 evidence with no E3 cohort-level disclosure, and the +200bps gap from 98 to 100 is material given the structural Online drag.

NDE flat at 98% for 4 consecutive quarters with no recovery curve visible is sharper bear evidence than the bull dilution narrative allows (Black Swan Beacon's 40/60 parsimonious read). The structural Online drag (39% of revenue, churn drifting 2.7%->2.9%, volume erosion masked by 6% price increase) and unverified-at-E3 Workvivo/ZCC dilution mechanism push below the 33% aggregate, but 4 independent FY27 quarters provide meaningful optionality if cohort math eventually resolves favorably. Zero insider open-market buys at $84 despite Yuan's 31% voting control is a behavioral signal that NEOs lack NDE-recovery conviction.

Question is a 'best-of-4-quarters' binary on combined Workplace+CX NDE crossing 100% in any FY27 quarter. Multi-shot structure provides meaningful lift over single-quarter base rate, but four key constraints pull the estimate below the threshold-equivalent neutrality of 0.40-0.45. (1) NDE has been pinned at 98% for 4+ consecutive quarters with no visible recovery curve — Black Swan Beacon's parsimonious read is correct: if Workvivo/ZCC dilution math were the operative mechanism, the 4-quarter rolling denominator should have already exhibited a measurable upward inflection. Flat 98% across the cohort-maturation window weakens the bull mechanism each quarter it persists. (2) Combined-metric resolution is binding — single-segment Enterprise-only disclosures don't qualify. The Online tier at 39% of revenue (~$1.9B), with monthly churn drifting from 2.7%→2.9% and volume erosion implied by +1-2% growth on a 6% mid-March price increase, structurally drags blended NDE regardless of Enterprise behavior. Even if Enterprise NDE is 105%+, the math doesn't pull combined to 100 unless Online stabilizes (unlikely in current macro context). (3) The TTM denominator structure means a 2pp NDE lift from 98→100 requires the most recent rolling quarter to be ~106-108% — a sharp inflection from current trajectory. (4) Zero insider open-market buys across the four-month Form 4 corpus despite Yuan's 31% voting control and maximum information advantage — strong revealed-preference signal that NEOs do not see imminent NDE recovery. Counter-pressures: 4/4 beat-and-raise FY26 (+140bps over initial revenue guide) shows management runs systematically conservative; FY27 guide of +4.1% midpoint (or +4.5% underlying ex-40bps white-label headwind) likely sandbags actual trajectory; >$100K customers +9% YoY indicates Enterprise mix-shift that mechanically lifts blended NDE; RPO +10%+ growing 2.4x revenue indicates contracted expansion backlog; AI Companion paid monetization is an unresolved upside vector. Quarter-by-quarter probability sequencing: Q1 FY27 ~6% (only one quarter of additional cohort aging), Q2 ~10%, Q3 ~14% (Workvivo FY25 cohort fully matured, AI Companion data may surface), Q4 ~14% (comp lapping). Naïve independent calculation yields P(any)≈0.42, but quarterly outcomes are highly correlated through the underlying mechanism — if Q1 prints 98 again, conditional P(Q2-Q4 hits 100) drops materially because the dilution-recovery hypothesis is further weakened. Correlation-adjusted aggregate ≈ 0.30-0.33. Settling at 0.31 with mild bearish lean from the 4-quarter lack-of-recovery evidence and Online structural drag, partially offset by management conservatism and multi-shot structure. Confidence MEDIUM because the two competing mechanisms (new-logo dilution vs existing-customer contraction) cannot be discriminated at E3 without cohort-level disclosure that ZM has chosen not to provide.

The question resolves YES if combined Workplace + CX NDE reaches >=100% in ANY of four FY27 quarters — four chances materially lifts the baseline above a single-quarter probability, but several structural anchors cap the upside. NDE has been flat at 98% for 4+ consecutive quarters with zero visible recovery curve. The Black Swan Beacon's parsimonious read is the correct one: if the new-logo dilution mechanism (Workvivo/ZCC cohorts depressing the trailing-12mo denominator) were operative, some recovery signal should be visible by Q4 FY26. Flat 98% for four quarters is sharper bear evidence than management's narrative allows. The Online tier (39% of revenue, ~$1.9B) is the structural drag that makes 100%+ recovery hardest — monthly churn drifting from 2.7% to 2.9% with implied volume erosion (only +1-2% growth on a 6% price increase) continuously pulls combined NDE below Enterprise-only levels. The resolution criteria require the COMBINED metric, so superior Enterprise cohort behavior does not resolve YES unless management explicitly states combined NDE >=100%. Zero open-market discretionary buys by insiders at ~$84 — despite Yuan's 31% voting control and maximum information advantage — is a meaningful behavioral signal against near-term NDE recovery confidence. On the bull side: 4 independent chances (Q1 through Q4 FY27) at approximately 12-14% per quarter cumulates to roughly 40-45%, and CX wins are real (high-double-digit growth, competitive displacements of Genesys/NICE/Five9). Management's conservatism track record (systematic beat-and-raise on revenue and margin) and RPO growing 2.4x faster than revenue suggest underlying demand is healthier than the NDE metric implies. But the gap between positive RPO/Enterprise signals and a flat NDE at 98% for 4+ quarters suggests the blended metric is being anchored by Online churn and new-logo cohort maturation taking longer than expected. I weight the bear mechanism at 55% and the bull mechanism at 45%, translating to a per-quarter YES probability of roughly 12-14%. Across 4 quarters with modest positive correlation (recovery in Q1 makes Q2 more likely), cumulative probability lands around 0.37 — slightly above the 0.33 aggregate but below the naive 4-shot calculation because the structural Online drag makes any single quarter's trajectory better described as 'muddling' than 'accelerating.'

Four consecutive quarters at exactly 98% is the dominant prior-setter — not noise, a pattern. The Black Swan Beacon's parsimonious read (40/60 lean bear on mechanism) is correct: if new-logo dilution from Workvivo/ZCC were self-correcting, at least a directional tick upward (even to 99%) would have appeared by now. The flat 98% across four quarters weakens the bull narrative with each passing quarter. The 2-point gap to the YES threshold (+200bps swing in the expansion/contraction ratio) requires either new-logo cohorts maturing into expansion territory or meaningful deceleration of contracting accounts — neither is catalyzed by disclosed near-term evidence. The Online tier (39% of revenue, churn drifting from 2.7% to 2.9%, +1-2% net growth on a 6% price increase implying material volume attrition) is a structural drag on blended NDE that does not self-resolve without macroeconomic relief. The 'any quarter' framing (4 attempts) provides a real base-rate uplift over a sustained-threshold market, but the steady-state at 98% keeps the threshold from feeling accessible. CX momentum (high-double-digit growth, competitive displacements real) is genuinely positive but CX is still a minority denominator in combined NDE math. Zero insider open-market buys at ~$84 across the full Form 4 corpus is a soft negative: Yuan at 31% voting control with maximum information advantage has not deployed personal capital on NDE recovery confidence. AI Companion paid upsell is the one credible swing catalyst not quantified in the context — if Enterprise account expansion accelerates via AI tiers, the math is doable, but this remains aspirational at E1 evidence. Net: 0.30, modestly below the ensemble aggregate of 0.33, reflecting the weight I assign the BSB bear-mechanism read and Online drag as durable rather than temporary headwinds.

Four consecutive quarters at 98% with no visible recovery curve is the most dispositive single fact. If new-logo dilution (Workvivo/ZCC cohorts depressing the trailing-12mo denominator) were the operative mechanism, some recovery signal should have materialized by now as those cohorts season — the flat trajectory is stronger bear evidence than the bull narrative typically concedes. Black Swan Beacon's 40/60 leaning-bear read on mechanism is the most disciplined interpretation of this pattern without cohort-level data to verify the dilution story. The Online tier (~39% of revenue) compounds the problem: 2.9% monthly churn in Q4 vs 2.7% in Q3, with +1-2% revenue growth on a 6% price increase implying volume erosion — this cohort structurally drags combined NDE downward regardless of Enterprise behavior. Resolution requires combined Workplace + CX NDE >=100%, not Enterprise-only (which may be higher), so the Online drag is not escapable. Zero open-market insider buys at ~$84 with Yuan holding 31% voting control and maximum information advantage is a behavioral signal against NDE-recovery confidence. Four FY27 quarters give four chances at a single YES, which is the primary reason this is 0.30 rather than lower — CX momentum (competitive wins against Genesys/NICE/Five9) and Workvivo maturation could produce a transient >=100% print in one quarter even without sustained recovery. But the FY27 revenue guide (+4.1%, with additional 40bps headwind from customer churn) does not suggest an acceleration environment that would naturally drive NDE expansion. On balance, the bear mechanism (structural existing-customer net contraction, not new-logo dilution) is more likely operative, and the probability of any single quarter crossing 100% in this environment is below one-in-three.

NDE stalled at 98% for 4+ consecutive quarters with no recovery curve visible. Bull mechanism (new-logo dilution from Workvivo/ZCC maturing into trailing-12mo denominator) is plausible but unverified at E2 evidence—management has not disclosed cohort-level retention curves or NDE methodology. Black Swan Beacon's parsimonious read: flat 98% is sharper bear evidence than the dilution narrative allows. Online tier (39% of revenue) shows structural drag: churn drifting up (2.7%→2.9%), volume erosion visible (+1-2% growth on 6% price increase). This cohort depresses blended NDE regardless of Enterprise performance. Enterprise-only NDE may be higher, but market resolution requires combined Workplace+CX metric, which management does not decompose. Beat-and-raise pattern (4 consecutive quarterly beats in FY26, +140bps cumulative) applies to revenue guidance, not NDE cohort math. Recovery to 100%+ within 4 quarters requires mechanism shift + timing compression; stagnation at 98% appears more mechanically consistent with existing-customer net contraction pressure from Teams bundling + AI substitution. Zero insider discretionary buys despite Yuan's maximum information advantage reinforces cautious read.

NDE stalled 4+ quarters at 98% with no recovery curve visible, contradicting bull case that dilution would show inflection by now. Black Swan's parsimonious read: flat metric is sharper bear evidence (40/60 lean bear on mechanism). Management's new-logo dilution narrative (Workvivo/ZCC depressing denominator) is E1 plausible but unverified—no cohort-level retention curves disclosed. For YES in FY27 requires either: (a) dilution math validates Q1 FY27 onward (committee 50% base, but 4 quarters flat weakens this), or (b) existing-customer expansion despite Teams bundling pressure (low given insider silence—Yuan hasn't deployed personal capital despite 31% voting control). Combined metric (Workplace + CX) binding constraint: Enterprise NDE likely >100%, but Online tier (39% revenue, 2.9% monthly churn rising from 2.7%) structurally drags the blend. Beat-and-raise pattern (4 consecutive Q beats, +140bps revenue guidance vs FY26 actual) applies to top-line, NOT NDE cohort math. No inference from revenue beat-track to NDE trajectory. Q1 FY27 (earliest resolution, ~2 weeks away) is high bar: need surprise inflection or Workvivo/ZCC mechanism validation. Risk: dilution story gets riskier with each flat quarter.

NDE flatlined at 98% for four consecutive quarters. Management's new-logo dilution narrative (Workvivo/ZCC depressing denominator) is plausible at E1 evidence but unverified at E2 — no cohort-level retention curves or NDE methodology disclosed. Black Swan Beacon flagged this as parsimonious 40/60 lean-bear: if dilution were operative, a recovery curve should be visible by now. Four-quarter flat 98% is sharper bear evidence than the bull case allows. Enterprise-only NDE may be materially higher, but market resolution requires combined Workplace + CX ≥100% — single-segment disclosures don't count. Online tier (39% revenue) remains structurally weak: Q4 monthly churn 2.9% up from 2.7%, volume erosion on 6% price increase (+1-2% growth). Denominator math requires both Workvivo/ZCC cohort maturation AND Enterprise-only NDE >115%+ masked by Online drag. Insider context (zero discretionary buys at $84 despite Yuan's 31% control) signals low confidence in imminent recovery.